Benign mammary epithelial cells enhance the transformed phenotype of human breast cancer cells

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Poczobutt, Joanna M ^a   Tentler, John ^b   Lu, Xian ^c   Schedin, Pepper J ^b   Gutierrez Hartmann, Arthur ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; PARAFORMALDEHYDE; CYTOKINE;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER GROWTH; CELL FUNCTION; CELL INTERACTION; CELL POPULATION; CELL STIMULATION; CELL TRANSFORMATION; CLONOGENIC ASSAY; COCULTURE; COLONY FORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; ANIMAL; BREAST; BREAST TUMOR; CELL COMMUNICATION; CELL CULTURE; CELL PROLIFERATION; CULTURE MEDIUM; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; METABOLISM; NUDE MOUSE; PATHOLOGY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CELL COMMUNICATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; CULTURE MEDIA, CONDITIONED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FEMALE; HUMANS; MICE; MICE, NUDE; PHENOTYPE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77954562207     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-373     Document Type: Article

References (43)

1. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002, 420(6917):860-867. 10.1038/nature01322, 2803035, 12490959.
2. Le Bitoux MA, Stamenkovic I. Tumor-host interactions: the role of inflammation. Histochem Cell Biol 2008, 130(6):1079-1090. 10.1007/s00418-008-0527-3, 18953558.
3. Mueller MM, Fusenig NE. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004, 4(11):839-849. 10.1038/nrc1477, 15516957.
4. Lyons TR, Schedin PJ, Borges VF. Pregnancy and breast cancer: when they collide. J Mammary Gland Biol Neoplasia 2009, 14(2):87-98. 10.1007/s10911-009-9119-7, 2693784, 19381788.
5. O'Brien J, Schedin P. Macrophages in breast cancer: do involution macrophages account for the poor prognosis of pregnancy-associated breast cancer?. J Mammary Gland Biol Neoplasia 2009, 14(2):145-157. 10.1007/s10911-009-9118-8, 2693782, 19350209.
6. Schedin P. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 2006, 6(4):281-291. 10.1038/nrc1839, 16557280.
7. Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007, 117(5):1175-1183. 10.1172/JCI31537, 1857251, 17476347.
8. Barcellos-Hoff MH, Ravani SA. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 2000, 60(5):1254-1260.
9. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004, 303(5659):848-851. 10.1126/science.1090922, 14764882.
10. Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, Richardson A, Violette S, Nikolskaya T, Nikolsky Y, Bauerlein EL, Hahn WC, Gelman RS, Allred C, Bissell MJ, Schnitt S, Polyak K. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 2008, 13(5):394-406. 10.1016/j.ccr.2008.03.007, 18455123.
11. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 2001, 98(21):12072-12077. 10.1073/pnas.211053698, 59769, 11593017.
12. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999, 59(19):5002-5011.
13. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121(3):335-348. 10.1016/j.cell.2005.02.034, 15882617.
14. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 449(7162):557-563. 10.1038/nature06188, 17914389.
15. Ronnov-Jessen L, Petersen OW, Koteliansky VE, Bissell MJ. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 1995, 95(2):859-873. 10.1172/JCI117736, 295570, 7532191.
16. Dolberg DS, Bissell MJ. Inability of Rous sarcoma virus to cause sarcomas in the avian embryo. Nature 1984, 309(5968):552-556. 10.1038/309552a0, 6203040.
17. Mintz B, Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci USA 1975, 72(9):3585-3589. 10.1073/pnas.72.9.3585, 433040, 1059147.
18. Postovit LM, Margaryan NV, Seftor EA, Kirschmann DA, Lipavsky A, Wheaton WW, Abbott DE, Seftor RE, Hendrix MJ. Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci USA 2008, 105(11):4329-4334. 10.1073/pnas.0800467105, 2393795, 18334633.
19. Man YG. Direct physical continuation of normal appearing breast tissues with malignant lesions. Proceedings of Era of Hope, Department of Defense Breast Cancer Research Program Meeting: 25-28 June 2008; Baltimore 2008, 479-479.
20. Man YG, Nieburgs HE. A subset of cell clusters with malignant features in morphologically normal-appearing and hyperplastic tissues. Cancer Detect Prev 2006, 30(3):239-247. 10.1016/j.cdp.2006.04.006, 16872754.
21. Carpenter PM, Nguyen HP. Mammary epithelium-induced motility of MCF-7 cells. Anticancer Res 1998, 18(2A):1063-1068.
22. Dong-Le Bourhis X, Berthois Y, Millot G, Degeorges A, Sylvi M, Martin PM, Calvo F. Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture. Int J Cancer 1997, 71(1):42-48. 10.1002/(SICI)1097-0215(19970328)71:1<42::AID-IJC9>3.0.CO;2-3, 9096664.
23. Quarrie LH, Pitts JD, Finbow ME. Interactions between normal mammary epithelial cells and mammary tumour cells in a model system. Cell Prolif 1999, 32(6):351-361. 10.1111/j.1365-2184.1999.tb01353.x, 10646687.
24. Serrati S, Margheri F, Fibbi G, Di Cara G, Minafra L, Pucci-Minafra I, Liotta F, Annunziato F, Pucci M, Del Rosso M. Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression. J Pathol 2008, 214(5):545-554. 10.1002/path.2309, 18189329.
25. Spink BC, Cole RW, Katz BH, Gierthy JF, Bradley LM, Spink DC. Inhibition of MCF-7 breast cancer cell proliferation by MCF-10A breast epithelial cells in coculture. Cell Biol Int 2006, 30(3):227-238. 10.1016/j.cellbi.2005.11.006, 16427788.
26. Toillon RA, Chopin V, Jouy N, Fauquette W, Boilly B, Le Bourhis X. Normal breast epithelial cells induce p53-dependent apoptosis and p53-independent cell cycle arrest of breast cancer cells. Breast Cancer Res Treat 2002, 71(3):269-280. 10.1023/A:1014422101452, 12002345.
27. McDaniel SM, Rumer KK, Biroc SL, Metz RP, Singh M, Porter W, Schedin P. Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis. Am J Pathol 2006, 168(2):608-620. 10.2353/ajpath.2006.050677, 1606507, 16436674.
28. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002, 295(5556):868-872. 10.1126/science.1067081, 11786607.
29. Sartorius CA, Shen T, Horwitz KB. Progesterone receptors A and B differentially affect the growth of estrogen-dependent human breast tumor xenografts. Breast Cancer Res Treat 2003, 79(3):287-299. 10.1023/A:1024031731269, 12846413.
30. Soule HD, Maloney TM, Wolman SR, Peterson WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990, 50(18):6075-6086.
31. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003, 30(3):256-268. 10.1016/S1046-2023(03)00032-X, 12798140.
32. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997, 137(1):231-245. 10.1083/jcb.137.1.231, 2139858, 9105051.
33. Schedin PJ, Eckel-Mahan KL, McDaniel SM, Prescott JD, Brodsky KS, Tentler JJ, Gutierrez-Hartmann A. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells. Oncogene 2004, 23(9):1766-1779. 10.1038/sj.onc.1207391, 14767472.
34. Fox CH, Johnson FB, Whiting J, Roller PP. Formaldehyde fixation. J Histochem Cytochem 1985, 33(8):845-853.
35. Samoszuk M, Tan J, Chorn G. Clonogenic growth of human breast cancer cells co-cultured in direct contact with serum-activated fibroblasts. Breast Cancer Res 2005, 7(3):R274-283. 10.1186/bcr995, 1143574, 15987422.
36. Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M, Ceccarelli C, Santini D, Paterini P, Marcu KB, Chieco P, Bonafe M. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 2007, 117(12):3988-4002. 10.1172/JCI32533, 2096439, 18060036.
37. Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 2005, 41(16):2502-2512. 10.1016/j.ejca.2005.08.016, 16199153.
38. Knupfer H, Preiss R. Significance of interleukin-6 (IL-6) in breast cancer (review). Breast Cancer Res Treat 2007, 102(2):129-135. 10.1007/s10549-006-9328-3, 16927176.
39. Boulanger CA, Smith GH. Reprogramming cell fates in the mammary microenvironment. Cell Cycle 2009, 8(8):1127-1132.
40. Boulanger CA, Mack DL, Booth BW, Smith GH. Interaction with the mammary microenvironment redirects spermatogenic cell fate in vivo. Proc Natl Acad Sci USA 2007, 104(10):3871-3876. 10.1073/pnas.0611637104, 1820676, 17360445.
41. Booth BW, Mack DL, Androutsellis-Theotokis A, McKay RD, Boulanger CA, Smith GH. The mammary microenvironment alters the differentiation repertoire of neural stem cells. Proc Natl Acad Sci USA 2008, 105(39):14891-14896. 10.1073/pnas.0803214105, 2567463, 18809919.
42. Monks J, Rosner D, Geske FJ, Lehman L, Hanson L, Neville MC, Fadok VA. Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ 2005, 12(2):107-114. 10.1038/sj.cdd.4401517, 15647754.
43. Monks J, Smith-Steinhart C, Kruk ER, Fadok VA, Henson PM. Epithelial cells remove apoptotic epithelial cells during post-lactation involution of the mouse mammary gland. Biol Reprod 2008, 78(4):586-594. 10.1095/biolreprod.107.065045, 18057312.